Cerebrovascular diseases: Post-stroke depression and anhedonia

Anhedonia: A Comprehensive Handbook Volume II: Neuropsychiatric and Physical Disorders

Volumn , Issue , 2014, Pages 301-318

  Calabrò, Rocco Salvatore ^a   Spadaro, Letteria ^a   Bramanti, Placido ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Cerebrovascular disorders; Leukoaraiosis; Post stroke depression; Psychosocial factors; Stroke; Vascular depression

Indexed keywords

EID: 84902380137     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-017-8610-2_15     Document Type: Chapter

References (92)

1. Lyden P, Lu M, Jackson C, Marler J, et al. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke. 1999;30(11):2347-54.
2. van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-7.
3. Dennis MS, Burn JP, Sandercock PA, et al. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24(6):796-800.
4. Pantoni L. Leukoaraiosis: from an ancient term to an actual marker of poor prognosis. Stroke. 2008;39(5):1401-3.
5. Pantoni L, Poggesi A, Basile AM, et al. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc. 2006;54(7):1095-101.
6. Teodorczuk A, Firbank MJ, Pantoni L, LADIS Group, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med. 2010;40:603-10.
7. Firbank MJ, Teodorczuk A, van der Flier WM, LADIS Group, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry. 2012;201:40-5.
8. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke. 1999;30(10):2159-66.
9. Kumar A, Bilker W, Lavretsky H, Gottlieb G. Volumetric asymmetries in late-onset mood disorders: an attenuation of frontal asymmetry with depression severity. Psychiatry Res. 2000;100(1):41-7.
10. Firbank MJ, Lloyd AJ, Ferrier N, O’Brien JT. A volumetric study of MRI signal hyperintensities in late-life depression. Am J Geriatr Psychiatry. 2004;12(6):606-12.
11. Hannestad J, Taylor WD, McQuoid DR, et al. White matter lesion volumes and caudate volumes in late-life depression. Int J Geriatr Psychiatry. 2006;21(12):1193-8.
12. Janssen J, Hulshoff Pol HE, de Leeuw FE, et al. Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. Neurol Neurosurg Psychiatry. 2007;78(6):638-40.
13. Verdelho A, Madureira S, Moleiro C, et al. Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: the LADIS study. J Neurol Neurosurg Psychiatry. 2013;84:1250-4. doi: 10.1136/jnnp-2012-304191.
14. Alexopoulos GS, Meyers BS, Young RC, et al. Clinically defined vascular depression. Am J Psychiatry. 1997;154(4):562-5.
15. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry. 1997;154(4):497-501.
16. Krishnan KR, McDonald WM. Arteriosclerotic depression. Med Hypotheses. 1995;44(2):111-5.
17. Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry. 2006;60(12):1304-5.
18. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998;43(10):705-12.
19. Alexopoulos GS. Frontostriatal and limbic dysfunction in late-life depression. Am J Geriatr Psychiatry. 2002;10(6):687-95.
20. Eaton WW, Kalaydjian A, Scharfstein DO, et al. Prevalence and incidence of depressive disorder:the Baltimore ECA follow-up, 1981-2004. Acta Psychiatr Scand. 2007;116(3):182-8.
21. Krishnan KR, Taylor WD, McQuoid DR, et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry. 2004;55(4):390-7.
22. Hickie I, Scott E, Mitchell P, et al. Subcortical hyperintensities on magnetic resonance imaging:clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37(3):151-60.
23. Newberg AR, Davydow DS, Lee HB. Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. Int Rev Psychiatry. 2006;18(5):433-41.
24. Miller JM, Vorel SR, Tranguch AJ, et al. Anhedonia after a selective bilateral lesion of the globus pallidus. Am J Psychiatry. 2006;163(5):786-8.
25. Steffens DC, Krishnan KR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002;33(6):1636-44.
26. Thomas AJ, Perry R, Barber R, et al. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci. 2002;977:333-9.
27. Kramer-Ginsberg E, Greenwald BS, Krishnan KR, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1999;156(3):438-44.
28. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961-70.
29. Kales HC, Maixner DF, Mellow AM. Cerebrovascular disease and late-life depression. Am J Geriatr Psychiatry. 2005;13(2):88-98.
30. Naarding P, Veereschild M, Bremmer M, et al. The symptom profile of vascular depression. Int J Geriatr Psychiatry. 2009;24(9):965-9.
31. De Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57(11):1071-6.
32. Taylor WD, Steffens DC, MacFall JR, et al. White matter hyperintensity progression and late- life depression outcomes. Arch Gen Psychiatry. 2003;60(11):1090-6.
33. Alexopoulos GS, Raue P, Areán P. Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction. Am J Geriatr Psychiatry. 2003;11(1):46-52.
34. Levy RM, Steffens DC, McQuoid DR, et al. MRI lesion severity and mortality in geriatric depression. Am J Geriatr Psychiatry. 2003;11(6):678-82.
35. Fischer CE, Jiang D, Schweizer TA. Determining the association of medical co-morbidity with subjective and objective cognitive performance in an inner city memory disorders clinic: a retrospective chart review. BMC Geriatr. 2010;10:89. Available at: http://www.biomedcentral. com/1471-2318/10/89/
36. Baldwin RC. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int J Geriatr Psychiatry. 2005;20(1):1-11.
37. Santos M, Kövari E, Gold G, et al. The neuroanatomical model of post-stroke depression:towards a change of focus? J Neurol Sci. 2009;283(1-2):158-62.
38. Sheline YI, Pieper CF, Barch DM, et al. Support for the vascular depression hypothesis in late- life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010;67(3):277-85.
39. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963-74. doi: 10.1038/mp.2013.20.
40. Thomas AJ, Kalaria RN, O’Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord. 2004;79(1-3):81-95.
41. Whyte EM, Mulsant BH. Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry. 2002;52(3):253-64.
42. Dieguez S, Staub F, Bruggimann L, et al. Is poststroke depression a vascular depression? J Neurol Sci. 2004;226(1-2):53-8.
43. American Psychiatric Association. Diagnostic and statistical manual of mental disorders:Fourth Edition Text Revision DSM-IV-TR®. Washington, DC: American Psychiatric Association; 2000.
44. Gordon WA, Hibbard MR. Poststroke depression: an examination of the literature. Arch Phys Med Rehabil. 1997;78(6):658-63.
45. Spencer KA, Tompkins CA, Schulz R. Assessment of depression in patients with brain pathology: the case of stroke. Psychol Bull. 1997;122(2):132-52.
46. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry. 2003;54(3):376-87.
47. De Wit L, Putman K, Baert I, et al. Anxiety and depression in the first six months after stroke. A longitudinal multicentre study. Disabil Rehabil. 2008;30(24):1858-66.
48. Srivastava A, Taly AB, Gupta A, Murali T. Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann Indian Acad Neurol. 2010;13(2):123-7.
49. Poynter B, Shuman M, Diaz-Granados N, et al. Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics. 2009;50(6):563-9.
50. Pohjasvaara T, Vataja R, Leppävuori A, et al. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol. 2001;8(4):315-9.
51. Paolucci S, Gandolfo C, Provinciali L, et al. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253(5):556-62.
52. Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry. 2010; 55(6):341-9.
53. Sibon I, Lassalle-Lagadec S, Renou P, et al. Evolution of depression symptoms following stroke: a prospective study using computerized ambulatory monitoring. Cerebrovasc Dis. 2012;33(3):280-5.
54. Beblo T, Wallesch CW, Herrmann M. The crucial role of frontostriatal circuits for depressive disorders in the postacute stage after stroke. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12(4):236-46.
55. Starkstein SE, Bryer JB, Berthier ML, et al. Depression after stroke: the importance of cerebral hemisphere asymmetries. J Neuropsychiatry Clin Neurosci. 1991;3(3):276-85.
56. Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry. 1989;154:170-82.
57. Fang J, Cheng Q. Etiological mechanisms of post-stroke depression: a review. Neurol Res. 2009;31(9):904-9.
58. Robinson RG, Kubos KL, Starr LB, et al. Mood disorders in stroke patients. Importance of location of lesion. Brain. 1984;107(1):81-93.
59. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain. 1987;110(4):1045-59.
60. Narushima K, Kosier JT, Robinson RG. A reappraisal of post-stroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci. 2003;15(4):422-30.
61. Agrell B, Dehlin O. Depression in stroke patients with left and right hemisphere lesions. A study in geriatric rehabilitation in-patients. Aging. 1994;6(1):49-56.
62. Altieri M, Maestrini I, Mercurio A, et al. Depression after minor stroke: prevalence and predictors. Eur J Neurol. 2012;19(3):517-21.
63. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry. 1999;175:163-7.
64. House A. Depression associated with stroke. Neuropsychiatry Clin Neurosci. 1996;8(4):453-7.
65. da Rocha e Silva CE, Alves Brasil MA, Matos do Nascimento E, et al. Is poststroke depression a major depression? Cerebrovasc Dis. 2013;35(4):385-91.
66. Farner L, Wagle J, Engedal K, et al. Depressive symptoms in stroke patients: a 13 month follow- up study of patients referred to a rehabilitation unit. J Affect Disord. 2010;127(1-3):211-8.
67. Berg A, Palomäki H, Lehtihalmes M. Poststroke depression: an 18-month follow-up. Stroke. 2003;34(1):138-43.
68. Gainotti G, Azzoni A, Razzano C, et al. The Post-Stroke Depression Rating Scale: a test specifically devised to investigate affective disorders of stroke patients. J Clin Exp Neuropsychol. 1997;19(3):340-56.
69. Calabrò RS, Italiano D, Militi D, et al. Levetiracetam-associated loss of libido and anhedonia. Epilepsy Behav. 2012;24(2):283-4.
70. Haslam J. Observations on madness and melancholy; including practical remarks on those diseases, together with cases, and an account of the morbid appearances on dissection. London:Callow; 1809.
71. Ribot T. La Psychologie des Sentiments. Paris: F. Alcan; 1896.
72. World Health Organization. ICD-10: international statistical classification of diseases and related health problems. 10th ed. Geneva: World Health Organization; 2004.
73. Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537-55.
74. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35(1):68-77.
75. Ho N, Sommers M. Anhedonia: a concept analysis. Arch Psychiatr Nurs. 2013;27(3):121-9.
76. Cohen AS, Najolia GM, Brown LA, Minor KS. The state-trait disjunction of anhedonia in schizophrenia: potential affective, cognitive and social-based mechanisms. Clin Psychol Rev. 2011;31(3):440-8.
77. Strauss GP, Gold JM. A new perspective on anhedonia in schizophrenia. Am J Psychiatry. 2012;169(4):364-73.
78. Komulainen T, Keränen AM, Rasinaho E, et al. Quitting a weight loss program is associated with anhedonia: preliminary findings of the Lifestyle Intervention Treatment Evaluation Study in northern Finland. Int J Circumpolar Health. 2011;70(1):72-8.
79. Cohen AS, Callaway DA, Najolia GM, et al. On “risk” and reward: investigating state anhedonia in psychometrically defined schizotypy and schizophrenia. J Abnorm Psychol. 2012;121(2):407-15.
80. Cohen AS, Couture SM, Blanchard JJ. Neuropsychological functioning and social anhedonia:three-year follow-up data from a longitudinal community high risk study. J Psychiatr Res. 2012;46(7):898-904.
81. Lee JS, Park HJ, Chun JW, et al. Neuroanatomical correlates of trait anhedonia in patients with schizophrenia: a voxel-based morphometric study. Neurosci Lett. 2011;489(2):110-4.
82. Steer RA. Self-reported inability to cry as a symptom of anhedonic depression in outpatients with a major depressive disorder. Psychol Rep. 2011;108(3):874-82.
83. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28(3):309-69.
84. Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36(2):241-63.
85. Wise RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res. 2008;14(2-3):169-83.
86. Carver CS. Affect and the functional bases of behavior: on the dimensional structure of affective experience. Personal Soc Psychol Rev. 2001;5(4):345-56.
87. Dickinson A, Balleine B. Motivational control of instrumental action. Curr Dir Psychol Sci. 1995;4(5):162-7.
88. Gard DE, Kring AM, Gard MG, et al. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93(1-3):253-60.
89. Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008;10(3):291-9.
90. Harvey PO, Pruessner J, Czechowska Y, et al. Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Mol Psychiatry. 2007;12:703. 767-775.
91. Keedwell PA, Andrew C, Williams SC, et al. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry. 2005;58(11):843-53.
92. Bartoli F, Lillia N, Lax A, et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat. 2013;2013:862978.